Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

18 Feb 2010 11:14

RNS Number : 3414H
Seymour Pierce Ltd
18 February 2010
 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

 

1. KEY INFORMATION

 

Name of exempt principal trader

Seymour Pierce Limited

Company dealt in

Fulcrum Pharma plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary 1p Shares

Date of dealing

17.02.10

 

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of securities purchased

 

Highest price paid (Note 3)

Lowest price paid (Note 3)

136,000

0.03150 GBP

0.03000 GBP

 

 

Total number of securities sold

 

Highest price received (Note 3)

Lowest price received (Note 3)

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 3)

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

18.02.10

Contact name

Caroline Woodyer

Telephone number

020 7107 8056

Name of offeree/offeror with which connected

Fulcrum Pharma plc

Nature of connection (Note 6)

Nomad and Broker

 

 

Notes

 

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMKKFDDDBKDQBD
Date   Source Headline
10th Jan 20087:01 amRNSProposed Board Changes
20th Dec 20075:35 pmRNSResult of AGM
26th Nov 20077:01 amRNSFinal Results
15th Nov 20077:01 amRNSNotice of Results/Trdg Update
6th Nov 20077:01 amRNSOpening of new US office
11th Oct 20077:01 amRNSContract Win
7th Sep 20077:01 amRNSRe Alliance
3rd Sep 20074:13 pmRNSDirector/PDMR Shareholding
20th Aug 20074:09 pmRNSDirector/PDMR Shareholding
17th Aug 20074:37 pmRNSAIM Rule 26
15th Aug 20077:01 amRNSTrading Update
17th May 20077:01 amRNSInterim Results
18th Apr 20074:46 pmRNSDirector/PDMR Shareholding
12th Apr 20071:40 pmRNSEGM Statement
19th Mar 200711:28 amRNSPlacing and Acquisition
21st Feb 20077:00 amRNSCompletion of Earn Out
21st Dec 20069:29 amRNSTotal Voting Rights
18th Dec 200612:52 pmRNSResult of AGM
15th Nov 20062:06 pmRNSDirector/PDMR Shareholding
9th Nov 20067:01 amRNSFinal Results
2nd Aug 20067:00 amRNSDirector/PDMR Shareholding
12th May 20067:01 amRNSEdinburgh Office Opens
9th May 20067:01 amRNSInterim Results
12th Apr 200610:30 amRNSContract with Celtic Pharma
5th Apr 20067:01 amRNSNanoCarrier Partnership
7th Mar 20067:01 amRNSBoard Appointment
9th Feb 20067:01 amRNSAcquisition of Quadramed Ltd
19th Dec 200512:09 pmRNSAGM Statement
14th Nov 200512:18 pmRNSDirector/PDMR Shareholding
9th Nov 20057:00 amRNSPreliminary Results
14th Sep 20057:02 amRNSTrading Update
18th May 20057:01 amRNSSyngenta Biopharma Agreement
18th May 20057:00 amRNSInterim Results
5th May 200512:20 pmRNSNotice of Interim Results
1st Mar 20057:03 amRNSPresent at Networking Evening
25th Jan 20057:00 amRNSPresentation with Addex
6th Jan 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.